https://orcid.org/0000-0001-7434-4576
References
- Finbloom D, Silver K, Newsome D, et al. Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity. J Rheumatol 1985;12:692.
- Olsen NJ, Schleich MA, Karp DR. Multifaceted effects of hydroxychloroquine in human disease. Semin Arthritis Rheum 2013;43:264–272.
- Geamnu A, Popa-Cherecheanu A, Marinescu B, et al. Retinal toxicity associated with chronic exposure to hydroxychloroquine and its ocular screening. Review. J Med Life 2014;7:322.
- de Mendonça RHF, Júnior OOM, Takahashi WY. Electrophysiologic findings in chloroquine maculopathy. Documenta Ophthalmol 2007;115:117–119.
- Marmor MF, Kellner U, Lai TY, et al. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology 2016;123:1386–1394.
- Guha S, Coffey EE, Lu W, et al. Approaches for detecting lysosomal alkalinization and impaired degradation in fresh and cultured RPE cells: evidence for a role in retinal degenerations. Exp Eye Res 2014;126:68–76.
- Rodriguez-Padilla JA, Hedges TR, Monson B, et al. High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy. Arch Ophthalmol 2007;125:775–780.
- Korthagen NM, Bastiaans J, van Meurs JC, et al. Chloroquine and hydroxychloroquine increase retinal pigment epithelial layer permeability. J Biochem Mol Toxicol 2015; 29:299–304.
- Chan T, Zhu L, Madigan MC, et al. Human organic anion transporting polypeptide 1A2 (OATP1A2) mediates cellular uptake of all-trans-retinol in human retinal pigmented epithelial cells. Br J Pharmacol 2015;172:2343–2353.
- Browning DJ. The prevalence of hydroxychloroquine retinopathy and toxic dosing, and the role of the ophthalmologist in reducing both. Am J Ophthalmol 2016;166:ix–xi.
- Wooten BR, Hammond BR, Land RI, et al. A practical method for measuring macular pigment optical density. Invest Ophthalmol Vis Sci 1999;40:2481–2489.
- Marmor MF. Comparison of screening procedures in hydroxychloroquine toxicity. Arch Ophthalmol 2012;130:461–469.
- Wolfe F, Marmor MF. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res 2010;62:775–784.
- Marmor MF, Melles RB. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy. Ophthalmology 2014;121:1257–1262.
- Van Norren D, Tiemeijer L. Spectral reflectance of the human eye. Vision Res 1986;26:313–320.
- Yoon YH, Cho KS, Hwang JJ, et al. Induction of lysosomal dilatation, arrested autophagy, and cell death by chloroquine in cultured ARPE-19 cells. Invest Ophthalmol Vis Sci 2010;51:6030–6037.
- Mititelu M, Wong BJ, Brenner M, et al. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging. JAMA Ophthalmol 2013;131:1187–1197.
- Bulut M, Akıdan M, Gözkaya O, et al. Optical coherence tomography angiography for screening of hydroxychloroquine-induced retinal alterations. Graefes Arch Clin Exp Ophthalmol 2018;256:2075–2081.
- Ahn SJ, Ryu SJ, Joung JY, et al. Choroidal thinning associated with hydroxychloroquine retinopathy. Am J Ophthalmol 2017;183:56–64.